来凯医药-B
港股通 官网
( 02105.hk)
市盈率-23.98市净率7.92股息率0%上市时间2023-06-29股价13.86港币涨跌幅3.43%成交金额1,861.29万港币换手率0.30%市值61.88亿港币H股市值61.88亿港币总股本4.46亿H股本4.46亿每手股数500上市至今年化投资收益率-3.34%港股通持仓占H股比例8.09% (4.91亿港币2026-01-02) 累计做空占H股比例1.79% (1.12亿港币2025-12-24)
所属三级行业生物技术 (恒生) 市盈率68.47市净率5.20股息率0.30%恒生:医疗保健业药品及生物科技生物技术
备注 (2): 双击编辑备注
发表讨论

来凯医药-B(02105) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1鄒國強Independent Non Executive Director - A/F2023-06-16--
2LI MinIndependent Non Executive Director2023-06-16--
3YIN Xu DongIndependent Non Executive Director2023-06-16--
4GU Xiang Ju JustinExecutive Director2022-05-09--
5孫淵Non Executive Director2022-04-28--
6吉冬梅Non Executive Director2022-04-282023-09-29
7王國瑋Non Executive Director2019-07-01--
8XIE LingExecutive Director2018-05-11--
9LU Xiang Yang ChrisExecutive DirectorChairman2016-07-29--